Decipher Biosciences, Inc.
14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded as renamed to Veracyte, Inc. (2023)
0
Ending by 2030
none
Next term end
When these terms end
Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
No patent on this record is in force and held under this name now.
Also on record: 14 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 3 abandoned
Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/261,638 | Use of Immune Content Scores Diagnostically to Predict Responsiveness of Prostate Cancer Patients to Immunotherapy | Jan 13, 2022 | Pending |
| 17/561,408 | Molecular Subtyping, Prognosis, and Treatment of Bladder Cancer | Dec 23, 2021 | Pending |
| 18/037,885 | Methods and Genomic Classifiers for Identifying Homologous Recombination Deficiency Prostate Cancer | Nov 18, 2021 | Pending |
| 17/390,674 | Genetic Signatures to Predict Prostate Cancer Metastasis and Identify Tumor Aggressiveness | Jul 30, 2021 | Abandoned |
| 17/346,106 | Cancer Diagnostics Using Biomarkers | Jun 11, 2021 | Abandoned |
| 17/915,646 | Genomic Classifiers for Prognosing and Treating Clinically Aggressive Luminal Bladder Cancer | Mar 31, 2021 | Pending |
| 17/611,545 | Non-Coding Rna for Subtyping of Bladder Cancer | May 12, 2020 | Pending |
| 17/311,995 | Transcriptomic Profiling for Prognosis of Breast Cancer to Identify Subjects Who May Be Spared Adjuvant Systemic Therapy | Dec 6, 2019 | Abandoned |